Clinical trials
Autoimmune Diseases trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
71 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 6 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 6 |
| 2025 | 6 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 42 |
| Recruiting | 14 |
| Active, not recruiting | 7 |
| Terminated | 5 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 9 |
| Human Genome Sciences Inc., a GSK Company | 5 |
| Immunovant Sciences GmbH | 5 |
| University of Cambridge | 4 |
| Takeda | 3 |
| Amgen | 2 |
| Bristol-Myers Squibb | 2 |
| Imcyse SA | 2 |
| Imperial College London | 2 |
| Kadmon Corporation, LLC | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Autoimmune Diseases | 71 |
| Immune System Diseases | 21 |
| Lupus Erythematosus, Systemic | 14 |
| Diabetes Mellitus, Type 1 | 9 |
| Connective Tissue Diseases | 8 |
| Diabetes Mellitus | 6 |
| Endocrine System Diseases | 6 |
| Glucose Metabolism Disorders | 6 |
| Arthritis, Rheumatoid | 5 |
| Autoimmune Diseases of the Nervous System | 5 |
Trials
Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.